Roche is a pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people’s lives. We have created truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
In the UK we employ over 2,000 people who work hard every day to bring our medicines and diagnostics to people who urgently need them. We work from bench to bedside - researching new medicines and diagnostics, running global clinical trials, and collaborating with the NHS to try to ensure rapid uptake and delivery of our products and services.
For more information: www.roche.co.uk
Providing an early, accurate diagnosis of Parkinsonian syndromes (PS) and dementia with Lewy bodies (DLB) can be challenging because symptoms do not always provide the whole picture.
GE Healthcare’s DaTSCANTM Ioflupane(123I) is a radiopharmaceutical that can assist in the evaluation of patients with suspected PS or DLB.
Full Prescribing Information here.
TauRx's mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation.
With 30 years of tau focused research, CEO Professor Wischik will present on “Tau pathology as a driver and drug target for clinical dementia in Alzheimer’s disease”.